Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 62 articles:
HTML format

Single Articles

    April 2021
  1. LUO S, Feofanova EV, Tin A, Tung S, et al
    Genome-wide association study of serum metabolites in the African American Study of Kidney Disease and Hypertension.
    Kidney Int. 2021 Apr 7. pii: S0085-2538(21)00361.
    PubMed     Abstract available

  2. CIL O, Chen X, Askew Page HR, Baldwin SN, et al
    A small molecule inhibitor of the chloride channel TMEM16A blocks vascular smooth muscle contraction and lowers blood pressure in spontaneously hypertensive rats.
    Kidney Int. 2021 Apr 6. pii: S0085-2538(21)00360.
    PubMed     Abstract available

    March 2021
  3. FOTI KE, Wang D, Chang AR, Selvin E, et al
    Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Kidney Int. 2021;99:686-695.
    PubMed     Abstract available

    September 2020
    Your blood pressure might be normal, but what about your podocytes?
    Kidney Int. 2020;98:545-547.
    PubMed     Abstract available

    July 2020
  5. PONTICELLI C, Podesta MA, Moroni G
    Hyperuricemia As a trigger of Immune Response in Hypertension and Chronic Kidney Disease.
    Kidney Int. 2020 Jul 7. pii: S0085-2538(20)30804.
    PubMed     Abstract available

    April 2020
  6. WEN Y, Crowley SD
    Connecting cytokines and cellular signals in the nephron during CKD and hypertension.
    Kidney Int. 2020;97:651-653.
    PubMed     Abstract available

    March 2020
  7. NGUYEN ITN, Klooster A, Minnion M, Feelisch M, et al
    Sodium thiosulfate improves renal function and oxygenation in L-NNA-induced hypertension in rats.
    Kidney Int. 2020 Mar 23. pii: S0085-2538(20)30262.
    PubMed     Abstract available

    February 2020
  8. FURUSHO T, Sohara E, Mandai S, Kikuchi H, et al
    Renal TNFalpha activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease.
    Kidney Int. 2020 Feb 8. pii: S0085-2538(19)31217.
    PubMed     Abstract available

    November 2019
  9. CHIANG HP, Chiu YW, Lee JJ, Hung CC, et al
    Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.
    Kidney Int. 2019 Nov 7. pii: S0085-2538(19)31114.
    PubMed     Abstract available

  10. EL KAROUI K, Boudhabhay I, Fremeaux-Bacchi V
    Atypical hemolytic uremic syndrome and hypertensive crisis.
    Kidney Int. 2019;96:1239.

    October 2019
    Caring for individuals with hypertension in CKD, especially those with low education.
    Kidney Int. 2019;96:820-822.
    PubMed     Abstract available

    September 2019
  12. PONTICELLI C, Moroni G
    Is preeclampsia a risk for end-stage renal disease?
    Kidney Int. 2019;96:547-549.
    PubMed     Abstract available

    August 2019
  13. DUPONT V, Colosio C, Hureaux M, Mokri L, et al
    The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient.
    Kidney Int. 2019;96:529-530.

    July 2019
  14. ALENCAR DE PINHO N, Levin A, Fukagawa M, Hoy WE, et al
    Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.
    Kidney Int. 2019 Jul 25. pii: S0085-2538(19)30512.
    PubMed     Abstract available

  15. LIU Y, Liang M
    Functional role of epigenetic regulation in the development of prenatal programmed hypertension.
    Kidney Int. 2019;96:10-12.

    June 2019
    The Dietary Approaches to Stop Hypertension (DASH) diet in chronic kidney disease: should we embrace it?
    Kidney Int. 2019;95:1296-1298.
    PubMed     Abstract available

    May 2019
  17. CAVERO T, Arjona E, Soto K, Caravaca-Fontan F, et al
    Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Kidney Int. 2019 May 31. pii: S0085-2538(19)30582.
    PubMed     Abstract available

  18. SELVASKANDAN H, Karavadra M, Paramesparan K, Glasby M, et al
    The Case | Microangiopathic hemolytic anemia in a young female.
    Kidney Int. 2019;95:1277-1278.

    April 2019
    Placental growth factor in pre-eclampsia: friend or foe?
    Kidney Int. 2019;95:730-732.

    March 2019
  20. LOUTRADIS C, Sarafidis PA, Ekart R, Papadopoulos C, et al
    The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30270.
    PubMed     Abstract available

  21. BANERJEE T, Crews DC, Tuot DS, Pavkov ME, et al
    Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30113.
    PubMed     Abstract available

    February 2019
  22. VAN ROEYEN CRC, Martin IV, Drescher A, Schuett KA, et al
    Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.
    Kidney Int. 2019 Feb 28. pii: S0085-2538(18)30920.
    PubMed     Abstract available

  23. RAMKUMAR N, Kohan DE
    The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome.
    Kidney Int. 2019 Feb 25. pii: S0085-2538(18)30918.
    PubMed     Abstract available

    December 2018
  24. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.

    October 2018
  25. AGARWAL R, Tu W
    Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30608.
    PubMed     Abstract available

    September 2018
  26. TYSON CC, Wyatt CM
    There's no place like home: is self-monitoring beneficial in hypertension management?
    Kidney Int. 2018;94:450-452.

  27. LUFT FC, Wagner CA
    Pendred, pendrin, pseudohypoaldosteronism type II, and renal tubular acidosis.
    Kidney Int. 2018;94:457-459.
    PubMed     Abstract available

    August 2018
  28. WYATT CM, Textor SC
    Emerging evidence on renal denervation for the treatment of hypertension.
    Kidney Int. 2018 Aug 26. pii: S0085-2538(18)30545.

  29. SUZUKI T, Abe T
    Crossloads of metabolism and CKD.
    Kidney Int. 2018;94:242-243.
    PubMed     Abstract available

    June 2018
  30. KARABOYAS A, Xu H, Morgenstern H, Locatelli F, et al
    DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
    Kidney Int. 2018 Jun 13. pii: S0085-2538(18)30253.
    PubMed     Abstract available

    April 2018
  31. LIU P, Wysocki J, Souma T, Ye M, et al
    Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation.
    Kidney Int. 2018 Apr 21. pii: S0085-2538(18)30176.
    PubMed     Abstract available

    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    PubMed     Abstract available

  33. WYATT CM, Chertow GM
    Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology.
    Kidney Int. 2018;93:768-770.

    March 2018
  34. WYATT CM, Crowley SD
    Intersection of salt- and immune-mediated mechanisms of hypertension in the gut microbiome.
    Kidney Int. 2018;93:532-534.

    February 2018
  35. DE MARCELLUS C, Baudouin V, Tanase A, Monet C, et al
    Severe neonatal hypertension revealing arterial tortuosity syndrome.
    Kidney Int. 2018;93:526.

  36. PARR SK, Matheny ME, Abdel-Kader K, Greevy RA Jr, et al
    Acute kidney injury is a risk factor for subsequent proteinuria.
    Kidney Int. 2018;93:460-469.
    PubMed     Abstract available

    January 2018
  37. ZOCCALI C, Mallamaci F
    The overdriven glomerulus as a cardiovascular risk factor.
    Kidney Int. 2018;93:13-15.
    PubMed     Abstract available

  38. KAMEL KS, Schreiber M, Halperin ML
    Renal potassium physiology: integration of the renal response to dietary potassium depletion.
    Kidney Int. 2018;93:41-53.
    PubMed     Abstract available

  39. REBOLDI G, Verdecchia P, Fiorucci G, Beilin LJ, et al
    Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes.
    Kidney Int. 2018;93:195-203.
    PubMed     Abstract available

  40. REBHOLZ CM, Selvin E, Liang M, Ballantyne CM, et al
    Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.
    Kidney Int. 2018;93:252-259.
    PubMed     Abstract available

  41. LU J, Hou X, Yuan X, Cui L, et al
    Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.
    Kidney Int. 2018;93:69-80.
    PubMed     Abstract available

    November 2017
  42. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    PubMed     Abstract available

    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    PubMed     Abstract available

    October 2017
  44. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    PubMed     Abstract available

    July 2017
  45. OWENS EA, Jie L, Reyes BAS, Van Bockstaele EJ, et al
    Elastin insufficiency causes hypertension, structural defects and abnormal remodeling of renal vascular signaling.
    Kidney Int. 2017 Jul 26. pii: S0085-2538(17)30352.
    PubMed     Abstract available

  46. NAVANEETHAN SD, Schold JD, Jolly SE, Arrigain S, et al
    Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30327.
    PubMed     Abstract available

    June 2017
  47. TITZE J, Luft FC
    Speculations on salt and the genesis of arterial hypertension.
    Kidney Int. 2017;91:1324-1335.
    PubMed     Abstract available

  48. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Abstract available

    May 2017
  49. LEW QJ, Jafar TH, Talaei M, Jin A, et al
    Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.
    Kidney Int. 2017 May 18. pii: S0085-2538(17)30214.
    PubMed     Abstract available

  50. RASHMI P, Colussi G, Ng M, Wu X, et al
    Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron.
    Kidney Int. 2017;91:1159-1177.
    PubMed     Abstract available

    April 2017
  51. HOY WE, Kopp JB, Mott SA, Winkler CA, et al
    Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.
    Kidney Int. 2017;91:990.

  52. GIANI JF, Eriguchi M, Bernstein EA, Katsumata M, et al
    Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity.
    Kidney Int. 2017;91:856-867.
    PubMed     Abstract available

    February 2017
  53. WEBSTER P, Lightstone L, McKay DB, Josephson MA, et al
    Pregnancy in chronic kidney disease and kidney transplantation.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30748.
    PubMed     Abstract available

  54. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    PubMed     Abstract available

    December 2016
  55. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Abstract available

  56. WYATT CM, Spence JD
    Folic acid supplementation and chronic kidney disease progression.
    Kidney Int. 2016;90:1144-1145.
    PubMed     Abstract available

    August 2016
  57. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Abstract available

  58. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.

    July 2016
  59. VANKALAKUNTI M, Vasavi B, Anitha A
    Intravascular large B-cell lymphoma: masquerade as membranoproliferative glomerulonephritis.
    Kidney Int. 2016;90:231-2.

    June 2016
  60. WEIR MR, Bakris GL, Gross C, Mayo MR, et al
    Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Kidney Int. 2016 Jun 24. pii: S0085-2538(16)30186.
    PubMed     Abstract available

    May 2016
  61. ERIKSEN BO, Stefansson VT, Jenssen TG, Mathisen UD, et al
    Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30073.
    PubMed     Abstract available

  62. MATHEW AT, Fishbane S, Obi Y, Kalantar-Zadeh K, et al
    Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
    Kidney Int. 2016 May 12. pii: S0085-2538(16)30054.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.